Jane Street’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
110,472
+5,423
| +5% | +$50.3K | ﹤0.01% | 2842 |
|
|
2025
Q1 | $770K | Buy |
+105,049
| New | +$770K | ﹤0.01% | 3374 |
|
|
2024
Q4 | – | Sell |
-124,542
| Closed | -$1.08M | – | 6411 |
|
|
2024
Q3 | $1.08M | Sell |
124,542
-69,470
| -36% | -$604K | ﹤0.01% | 3283 |
|
|
2024
Q2 | $1.33M | Sell |
194,012
-58,344
| -23% | -$399K | ﹤0.01% | 3275 |
|
|
2024
Q1 | $2.3M | Buy |
252,356
+121,251
| +92% | +$1.1M | ﹤0.01% | 2146 |
|
|
2023
Q4 | $585K | Buy |
131,105
+70,741
| +117% | +$316K | ﹤0.01% | 3934 |
|
|
2023
Q3 | $190K | Sell |
60,364
-196,904
| -77% | -$618K | ﹤0.01% | 4428 |
|
|
2023
Q2 | $1.33M | Buy |
257,268
+140,222
| +120% | +$724K | ﹤0.01% | 2791 |
|
|
2023
Q1 | $617K | Buy |
117,046
+89,423
| +324% | +$471K | ﹤0.01% | 3439 |
|
|
2022
Q4 | $77.6K | Buy |
27,623
+4,965
| +22% | +$14K | ﹤0.01% | 4777 |
|
|
2022
Q3 | $94K | Sell |
22,658
-24,286
| -52% | -$101K | ﹤0.01% | 4920 |
|
|
2022
Q2 | $189K | Buy |
+46,944
| New | +$189K | ﹤0.01% | 4483 |
|
|
2022
Q1 | – | Sell |
-16,875
| Closed | -$118K | – | 6043 |
|
|
2021
Q4 | $118K | Sell |
16,875
-39,682
| -70% | -$277K | ﹤0.01% | 4609 |
|
|
2021
Q3 | $565K | Buy |
56,557
+14,262
| +34% | +$142K | ﹤0.01% | 3300 |
|
|
2021
Q2 | $599K | Buy |
42,295
+1,049
| +3% | +$14.9K | ﹤0.01% | 3222 |
|
|
2021
Q1 | $677K | Buy |
41,246
+5,193
| +14% | +$85.2K | ﹤0.01% | 2988 |
|
|
2020
Q4 | $746K | Buy |
36,053
+5,927
| +20% | +$123K | ﹤0.01% | 2387 |
|
|
2020
Q3 | $229K | Buy |
+30,126
| New | +$229K | ﹤0.01% | 3114 |
|
|
2020
Q2 | – | Sell |
-23,779
| Closed | -$118K | – | 4337 |
|
|
2020
Q1 | $118K | Buy |
+23,779
| New | +$118K | ﹤0.01% | 3069 |
|
|
2018
Q3 | – | Sell |
-13,489
| Closed | -$91K | – | 3783 |
|
|
2018
Q2 | $91K | Buy |
+13,489
| New | +$91K | ﹤0.01% | 3070 |
|